Pembrolizumab in Treating Patients With Extensive Stage Small Cell Lung Cancer After Completion of Combination Chemotherapy

Clinical Trial ID NCT02359019

PubWeight™ 6.69^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02359019

Top papers